文献速递胸部技术与安全CT

超越结节:身体组成作为未来肺癌风险的生物标志物

Beyond nodules: body composition as a biomarker for future lung cancer.
PubMed 文献 · Eur Radiol · 2025-06-06

本研究基于PLuSS(n=3635,随访22年)和NLST-ACRIN(n=16360,随访8年)两个队列的低剂量CT,自动分割皮下脂肪、内脏脂肪、肌内脂肪、骨骼肌和骨五种组织并计算体积与密度指标,构建包含年龄、吸烟状态及身体组成指标的Cox模型预测肺癌风险,PLuSS队列21年平均AUC为0.77(0.75-0.79),NLST外部验证7年AUC为0.63-0.66。

要点

  • 骨体积(HR=1.38)与骨密度(HR=0.80)、骨骼肌密度(HR=0.62)、肌内脂肪比(HR=0.65)、皮下脂肪体积(HR=0.76)均与肺癌风险独立相关。
  • 基于低剂量CT的身体组成指标联合年龄和吸烟状态可提升肺癌风险分层,PLuSS队列21年平均AUC为0.77(0.75-0.79)。
  • 外部验证NLST队列7年AUC为0.63-0.66,合并数据集21年平均AUC为0.71(0.70-0.72)。

核心结论

  • 通过低剂量CT评估的三维身体组成指标是肺癌风险的显著预测因子。

研究设计与样本

  • 回顾性研究,使用PLuSS队列(n=3635,随访22年)和NLST-ACRIN队列(n=16360,随访8年)的低剂量CT扫描,用团队既往开发的算法自动分割五种身体组织并计算体积和密度指标,采用病因特异性Cox比例风险模型评估HR,用时变AUC-ROC评价模型性能,并按不同风险组估计累积发病率函数。

关键影像表现/征象

  • 自动分割的五种身体组织包括皮下脂肪(SAT)、内脏脂肪(VAT)、肌内脂肪(IMAT)、骨骼肌(SM)和骨。
  • 最终复合模型包含年龄(HR=1.30,95%CI 1.17-1.43)、当前吸烟状态(HR=1.85,95%CI 1.49-2.28)、骨体积(HR=1.38,95%CI 1.25-1.52)、骨密度(HR=0.80,95%CI 0.71-0.89)、骨骼肌密度(HR=0.62,95%CI 0.58-0.66)、肌内脂肪比(HR=0.65,95%CI 0.58-0.73)和皮下脂肪体积(HR=0.76,95%CI 0.67-0.87)。

诊断标准与关键数值

  • PLuSS队列训练的模型在21年期间预测肺癌的平均AUC为0.77(95%CI 0.75-0.79),前7年平均AUC为0.71(95%CI 0.68-0.74)。
  • 在NLST队列外部验证中,7年随访期间AUC范围为0.63至0.66。
  • PLuSS与NLST合并数据集训练的模型在21年期间平均AUC为0.71(95%CI 0.70-0.72)。

临床应用与阅片要点

  • 肺癌风险分层可通过身体组成特征得到改善,为个性化肺癌筛查策略提供指导。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate if body composition can serve as a biomarker for assessing the risk of developing lung cancer.

MATERIALS AND METHODS: We conducted a retrospective study using low-dose computed tomography (LDCT) scans from the Pittsburgh lung screening study (PLuSS) (n = 3635, 22 follow-up years) and the NLST-ACRIN (n = 16,360, 8 follow-up years) cohort. Five types of body tissues, including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), intramuscular adipose tissue (IMAT), skeletal muscle (SM), and bone, were automatically segmented by our previously developed algorithms. Volume and density metrics were computed. Cause-specific Cox proportional hazards models were utilized to assess hazard ratios (HRs). Time-dependent area under the receiver operating characteristic curve (AUC-ROC) was used to evaluate model performance. The cumulative incidence function was estimated for different risk groups.

RESULTS: The final composite models were formed by age (HR = 1.30 (95% CI: 1.17-1.43)), current smoking status (HR = 1.85 (1.49-2.28)), bone volume (HR = 1.38 (1.25-1.52)), bone density (HR = 0.80 (0.71-0.89)), SM density (HR = 0.62 (0.58-0.66)), IMAT ratio (HR = 0.65 (0.58-0.73)), and SAT volume (HR = 0.76 (0.67-0.87)). The model trained on the PLuSS cohort achieved a mean AUC of 0.77 (0.75-0.79) over 21 years and 0.71 (0.68-0.74) over the first 7 years for lung cancer prediction. External validation on the NLST cohort yielded AUC values ranging from 0.63 to 0.66 over a 7-year follow-up period. The model trained on a combined dataset of PLuSS and NLST achieved a mean AUC of 0.71 (0.7-0.72) over 21 years.

CONCLUSION: Three-dimensional body composition metrics assessed through LDCT are a significant predictor of lung cancer risk.

KEY POINTS: Question Is body composition a biomarker for lung cancer risk assessment? Findings Body composition metrics derived from low-dose CT scans, including volumes and densities of fat, bone, and muscle, are strong predictors of lung cancer risk. Clinical relevance Lung cancer risk stratification can be improved by body composition features, providing guidance for personalized lung cancer screening strategies.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wang J, Leader JK, Meng X, et al. Beyond nodules: body composition as a biomarker for future lung cancer. Eur Radiol. 2025. PMID: 40478347. doi:10.1007/s00330-025-11735-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。